StockData
Climb Bio, Inc. logo

Climb Bio, Inc. (CLYM) income statement

CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$9.19−0.09 (-0.97%)

Close on Nov 20, 2026Market cap $527.84MP/E –Yield –

See a number that looks wrong?